|
FBXO38 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.436400E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.070360E-02 |
| Normal-vs-Stage2 |
6.279800E-02 |
| Normal-vs-Stage3 |
8.020400E-04 |
| Normal-vs-Stage4 |
2.994300E-04 |
| Stage1-vs-Stage2 |
9.939800E-01 |
| Stage1-vs-Stage3 |
1.776240E-01 |
| Stage1-vs-Stage4 |
1.065770E-01 |
| Stage2-vs-Stage3 |
3.817200E-01 |
| Stage2-vs-Stage4 |
2.294800E-01 |
| Stage3-vs-Stage4 |
5.860600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.960610E-03 |
| Normal-vs-AfricanAmerican |
2.377800E-01 |
| Normal-vs-Asian |
4.415700E-02 |
| Caucasian-vs-AfricanAmerican |
3.391000E-01 |
| Caucasian-vs-Asian |
7.023200E-01 |
| AfricanAmerican-vs-Asian |
5.913400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.643900E-03 |
| Normal-vs-Female |
2.397000E-03 |
| Male-vs-Female |
8.020400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.230100E-02 |
| Normal-vs-Age(41-60Yrs) |
4.576900E-04 |
| Normal-vs-Age(61-80Yrs) |
5.409500E-04 |
| Normal-vs-Age(81-100Yrs) |
9.515700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.280840E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.087780E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.095000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.842800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.843200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.289000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.343500E-02 |
| Classical-VS-Follicular |
1.811640E-02 |
| Classical-VS-Other |
2.856600E-01 |
| Classical-VS-Normal |
3.742100E-02 |
| Tall-VS-Follicular |
7.965200E-01 |
| Tall-VS-Other |
8.991000E-01 |
| Tall-VS-Normal |
1.217790E-03 |
| Follicular-VS-Other |
8.066800E-01 |
| Follicular-VS-Normal |
8.440400E-04 |
| Other-VS-Normal |
4.506300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.610100E-04 |
| Normal-vs-N1 |
3.716600E-03 |
| N0-vs-N1 |
5.759600E-01 |
|
|
